| 產(chǎn)品名稱 | TGX 221 |
| 產(chǎn)品貨號(hào) | Axon 1417 CAS [663619-89-4] MF C21H24N4O2MW 364.44 Purity: 99% Soluble in DMSO Description Potent and specific PI3K p110β inhibitor References Certificates Categories Extra info SP?Jackson?et al. PI 3-kinase p110b: A new target for antithrombotic therapy. Nature Medicine 2005,?11(5),?507-514. ? BT Hennessy?et al. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 2005,?4988-1004. ? AM Condliffe et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005, 106, 1432-1440. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology PI3K PI3K-Akt-mTOR EC 2.7.1.153 PI3K inhibitor (p110 β specific) Chemical name 7-methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]-pyrimidin-4-one Parent CAS No. [663619-89-4] Order Size Unit Price Stock 2 mg €70.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
TGX 221Axon 1417 CAS [663619-89-4] MF C21H24N4O2
Description
Potent and specific PI3K p110β inhibitor
PI3K inhibitor (p110 β specific)
Chemical name7-methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]-pyrimidin-4-one Parent CAS No.[663619-89-4] |
| 產(chǎn)品資料 |
